Attana AB

Attana at European Antibody Congress 2009

Evenemang

30
NOV
Geneva, Switzerland
-   -

Europe’s largest forum for the advancement of antibody discovery and development.

Dr. Simon Brack, Head of Lead Discovery at Covagen AG, Zürich, user of Attana A200 will present under the subject of: The SH3-domain of Fyn Kinase as a Scaffold for the Generation of Novel Binding Proteins. Dr. Simon Brack's speech is scheduled for the 1st of December and the Attana A200 system will be exhibited during the entire congress.

www.terrapinn.com/2009/antibodyeu/